These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15450786)

  • 1. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.
    Argyropoulos SV; Hood SD; Adrover M; Bell CJ; Rich AS; Nash JR; Rich NC; Witchel HJ; Nutt DJ
    Biol Psychiatry; 2004 Oct; 56(7):503-9. PubMed ID: 15450786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
    Hood SD; Hince DA; Davies SJ; Argyropoulos S; Robinson H; Potokar J; Nutt DJ
    Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder.
    Corchs F; Nutt DJ; Hood S; Bernik M
    Biol Psychiatry; 2009 Jul; 66(1):17-24. PubMed ID: 19268914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders.
    Davies SJ; Hood SD; Argyropoulos SV; Morris K; Bell C; Witchel HJ; Jackson PR; Nutt DJ; Potokar JP
    J Clin Psychopharmacol; 2006 Aug; 26(4):414-8. PubMed ID: 16855462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.
    Tõru I; Shlik J; Maron E; Vasar V; Nutt DJ
    Psychopharmacology (Berl); 2006 May; 186(1):107-12. PubMed ID: 16541242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants.
    O'Reardon JP; Chopra MP; Bergan A; Gallop R; DeRubeis RJ; Crits-Christoph P
    Biol Psychiatry; 2004 May; 55(9):957-9. PubMed ID: 15110741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: preliminary results.
    Külz AK; Meinzer S; Kopasz M; Voderholzer U
    Neuropsychobiology; 2007; 56(2-3):127-31. PubMed ID: 18259085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute tryptophan depletion in depressed patients treated with a selective serotonin-noradrenalin reuptake inhibitor: augmentation of antidepressant response?
    Booij L; Van der Does AJ; Haffmans PM; Riedel WJ
    J Affect Disord; 2005 Jun; 86(2-3):305-11. PubMed ID: 15935252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study.
    Praschak-Rieder N; Hussey D; Wilson AA; Carella A; Lee M; Dunn E; Willeit M; Bagby RM; Houle S; Meyer JH
    Biol Psychiatry; 2004 Oct; 56(8):587-91. PubMed ID: 15476688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety and depression: individual entities or two sides of the same coin?
    Nutt D
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():19-24. PubMed ID: 24930685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan depletion in SSRI-recovered depressed outpatients.
    Spillmann MK; Van der Does AJ; Rankin MA; Vuolo RD; Alpert JE; Nierenberg AA; Rosenbaum JF; Hayden D; Schoenfeld D; Fava M
    Psychopharmacology (Berl); 2001 May; 155(2):123-7. PubMed ID: 11400999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients.
    Berney A; Sookman D; Leyton M; Young SN; Benkelfat C
    Biol Psychiatry; 2006 May; 59(9):853-7. PubMed ID: 16213470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder.
    Faria V; Appel L; Åhs F; Linnman C; Pissiota A; Frans Ö; Bani M; Bettica P; Pich EM; Jacobsson E; Wahlstedt K; Fredrikson M; Furmark T
    Neuropsychopharmacology; 2012 Sep; 37(10):2222-32. PubMed ID: 22617357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.